0001728117-23-000018.txt : 20230322
0001728117-23-000018.hdr.sgml : 20230322
20230322171452
ACCESSION NUMBER: 0001728117-23-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230322
DATE AS OF CHANGE: 20230322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hasnain Faheem
CENTRAL INDEX KEY: 0001352620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 23753704
MAIL ADDRESS:
STREET 1: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_167951967938039.xml
FORM 4
X0407
4
2023-03-20
0
0001728117
Gossamer Bio, Inc.
GOSS
0001352620
Hasnain Faheem
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
0
Common Stock
2023-03-20
4
P
0
168683
1.0344
A
3786008
I
By family trust
Common Stock
2023-03-21
4
P
0
269389
1.1965
A
4055397
I
By family trust
Common Stock
2023-03-22
4
P
0
440500
1.1432
A
4495897
I
By family trust
Common Stock
143465
D
Stock Option (Right to Buy)
1.21
2023-03-20
4
A
0
544500
0
A
2033-03-19
Common Stock
544500.0
544500
D
This transaction was executed in multiple trades at prices ranging from $0.97 to 1.09 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
This transaction was executed in multiple trades at prices ranging from $1.155 to $1.21 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
This transaction was executed in multiple trades at prices ranging from $1.06 to $1.20 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
/s/ Jeff Boerneke, Attorney-in-Fact
2023-03-22